StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) income statement

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.77−0.06 (-6.87%)

Close on Nov 19, 2026Market cap $9.14MP/E –Yield –

CytoMed Therapeutics Ltd income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
–
Operating margin
–
Net margin
-1227.1%
Return on equity, FY2025
-51.3%

Financial strength

Current ratio
5.17
Debt to equity
0.06
Debt to assets
5.1%
Cash to current liabilities
295.5%

Valuation

P/E ratio
–
Price to sales
36.31
Price to book
1.80
Dividend yield
–

See a number that looks wrong?